Israel - heprea - Ministry of Health

ג'י.וי קוסמטיקס בעמ - עיצוב וריכוך השיער

Israel - heprea - Ministry of Health

ג'י.וי קוסמטיקס בעמ - עיצוב השיער

Israel - heprea - Ministry of Health

ג'י.וי קוסמטיקס בעמ - טיפוח השיער ותוספת ברק

Israel - heprea - Ministry of Health

ג'י.וי קוסמטיקס בעמ - מבריק שיער

Israel - heprea - Ministry of Health

medison pharma ltd - interferon beta 1a 30 mcg/vial - powder for solution for injection - interferon beta-1a - avonex is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. avonex is also indicated for the treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

Israel - heprea - Ministry of Health

medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.

Israel - heprea - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 1000 iu - coagulation factor vii

Israel - heprea - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 1500 iu - coagulation factor viii

Israel - heprea - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 2000 iu - coagulation factor viii

Israel - heprea - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 250 iu - coagulation factor vii